Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in NEO — Neogenomics Inc

CIK 861177 NEW YORK, NY

Position in NEO

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$2,670,549
-$1,455,407 QoQ
Shares Held
359,913
+2.6% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 52% Shared 0% None 48%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,969,794,403 across 32 Diagnostics & Research names. NEO ranks #23 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,670,549 359,913
2025-12-31 $4,125,956 350,847
2025-09-30 $2,727,148 353,258
2025-06-30 $4,252,859 581,787
2025-03-31 $4,720,807 497,451
2024-12-31 $10,647,906 646,111
2024-09-30 $8,897,432 603,216
2024-06-30 $8,688,927 626,455
2024-03-31 $6,618,415 421,019
2023-12-31 $6,532,704 403,752
2023-09-30 $5,135,073 417,486
2023-06-30 $6,355,119 395,465
2023-03-31 $6,885,041 395,465
2022-09-30 $3,254,292 377,967
2022-06-30 $3,351,058 411,173
2022-03-31 $5,156,722 424,422
2021-12-31 $14,655,968 429,542
2021-09-30 $21,133,746 438,096
2021-06-30 $20,254,269 448,401
2021-03-31 $22,197,420 460,241
2020-12-31 $24,501,073 455,072
2020-09-30 $17,263,115 467,962
2020-06-30 $14,421,310 465,504
2020-03-31 $12,348,515 447,248